Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone

Objective To determine the prognostic utility of serum pre-albumin in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone (AA). Patients and Methods 112 chemotherapy pretreated or chemotherapy-naive patients were scheduled for systemic treatment with AA. Serum p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Liancheng, Chi, Chenfei, Guo, Sanwei, Wang, Yanqing, Cai, Wen, Shao, Xiaoguang, Xu, Fan, Pan, Jiahua, Zhu, Yinjie, Shangguan, Xun, Xin, Zhixiang, Hu, Jianian, Qian, Hongyang, Xie, Shaowei, Wang, Rui, Zhou, Lixin, Dong, Baijun, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687158/
https://www.ncbi.nlm.nih.gov/pubmed/29151928
http://dx.doi.org/10.7150/jca.21134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687158/
https://www.ncbi.nlm.nih.gov/pubmed/29151928
http://dx.doi.org/10.7150/jca.21134

Ejemplares similares